Measles Virus-Based Treatments Trigger a Pro-inflammatory Cascade and a Distinctive Immunopeptidome in Glioblastoma-Reference-Cited by-同舟云学术

Measles Virus-Based Treatments Trigger a Pro-inflammatory Cascade and a Distinctive Immunopeptidome in Glioblastoma

Published:2019-03 Issue: Volume:12 Page:147-161
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Rajaraman Srinath,Canjuga Denis,Ghosh Michael,Codrea Marius Cosmin,Sieger Raika,Wedekink Florian,Tatagiba Marcos,Koch Marilin,Lauer Ulrich M.,Nahnsen Sven,Rammensee Hans-Georg,Mühlebach Michael D.,Stevanovic Stefan,Tabatabai Ghazaleh

Funder

Wilhelm Sander Foundation

Else Kröner Forschungskolleg “Therapieresistenz solider Tumore”

Deutsche Forschungsgemeinschaft

Deutsche Krebshilfe

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference73 articles.

1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol.,2009

2. A randomized trial of bevacizumab for newly diagnosed glioblastoma;Gilbert;N. Engl. J. Med.,2014

3. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial;Gilbert;J. Clin. Oncol.,2013

4. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma;Chinot;N. Engl. J. Med.,2014

5. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial;Stupp;JAMA,2017

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of Oncolytic Virus;Journal of Biomedical Nanotechnology;2024-10-01

2. Improvement of current immunotherapies with engineered oncolytic viruses that target cancer stem cells;Cell Biochemistry and Function;2024-06

3. Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?;Current Treatment Options in Oncology;2024-04-23

4. Stem Cells and Tumor-Killing Virus to Target Brain Tumor: In Pursuit to Bring a Potential Delivery Vehicle for the Central Nervous System Tumors;Current Drug Delivery;2024-01

5. Oncolytic Viruses in the Era of Omics, Computational Technologies, and Modeling: Thesis, Antithesis, and Synthesis;International Journal of Molecular Sciences;2023-12-12